| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Osteoactivin | Human Osteoactivin / GPNMB Protein, His Tag, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $340.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Glembatumumab vedotin | CR-011; CDX-011; CR-011-ADC; CR011-vcMMAE | Phase 2 Clinical | Celldex Therapeutics | Breast Neoplasms; Carcinoma, Squamous Cell; Melanoma; Osteosarcoma; Skin Melanoma; Solid tumours; Triple Negative Breast Neoplasms; Uveal melanoma | Details |
| GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (AHS Cancer Control Alberta) | GCAR1 | Phase 1 Clinical | AHS Cancer Control Alberta | Carcinoma, Renal Cell; Sarcoma; Sarcoma, Alveolar Soft Part; Triple Negative Breast Neoplasms | Details |
